abnormal liver development_Met<tm2Kln>/Met<tm2Kln>

http://metadb.riken.jp/0000596I129SvC57BL6CD1Mettm2KlnMettm2KlnMettm2Kln

abnormal liver development_Met<tm2Kln>/Met<tm2Kln>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• met proto-oncogene
  http://metadb.riken.jp/db/mgi_rdf/MGI:96969

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Met<tm2Kln>/Met<tm2Kln>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Met<tm2Kln>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * C57BL/6 * CD-1

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal liver development
  http://purl.obolibrary.org/obo/MP_0000596

文献

http://purl.org/net/cito/citesAsAuthority

• F. Maina, et.al., Coupling Met to specific pathways results in distinct developmental outcomes., Molecular cell, 2001, 7
  http://rdf.ncbi.nlm.nih.gov/pubmed/11430831